user

Independent validation of a prognostic genomic profile (ColoPrint) for stage II colon cancer (CC) patients

被引：2
|
作者：
Rosenberg, R.
Maak, M.
Nitsche, U.
Schuster, T.
Kuenzli, B.
Snel, M.
Simon, I.
Janssen, K.
Friess, H.
机构：
[1] Tech Univ Munich, Klinikum Rechts Isar, Dept Surg, D-80290 Munich, Germany
[2] Tech Univ Munich, Klinikum Rechts Isar, Dept Epidemiol & Stat, D-80290 Munich, Germany
[3] Agendia BV, Amsterdam, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.3513
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3513
引用
收藏
页数：1
相关论文
共 50 条
  • [31] PROgnostic Signature in stage II colon cancer (CC) patients enrolled in the phase III clinical trial TOSCA: PROSIT study
    Puccini, A.
    Ferrando, L.
    Mazzarella, L.
    Frige, G.
    Pessino, A.
    Pastorino, A.
    Martelli, V.
    Garuti, A.
    Ballestrero, A.
    Torri, V.
    Labianca, R.
    Fassan, M.
    Lonardi, S.
    Zoppoli, G.
    Sobrero, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S13 - S13
  • [32] The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients
    Farina-Sarasqueta, A.
    van Lijnschoten, G.
    Moerland, E.
    Creemers, G. -J.
    Lemmens, V. E. P. P.
    Rutten, H. J. T.
    van den Brule, A. J. C.
    ANNALS OF ONCOLOGY, 2010, 21 (12) : 2396 - 2402
  • [33] Is High-Grade Tumor Budding an Independent Prognostic Factor in Stage II Colon Cancer?
    Kyong Shin, Jung
    Ah Park, Yoon
    Wook Huh, Jung
    Hyeon Yun, Seong
    Cheol Kim, Hee
    Yong Lee, Woo
    Hyung Kim, Seok
    Yun Ha, Sang
    Cho, Yong Beom
    DISEASES OF THE COLON & RECTUM, 2023, 66 (08) : E801 - E808
  • [34] Prognostic factors for patients with stage II colon cancer: results of a prospective study
    Zhang, Chenghai
    Di, Jiabo
    Jiang, Beihai
    Cui, Ming
    Wang, Zaozao
    Xing, Jiadi
    Yang, Hong
    Yao, Zhendan
    Zhang, Nan
    Su, Xiangqian
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2016, 31 (01) : 123 - 129
  • [35] Prognostic factors for patients with stage II colon cancer: results of a prospective study
    Chenghai Zhang
    Jiabo Di
    Beihai Jiang
    Ming Cui
    Zaozao Wang
    Jiadi Xing
    Hong Yang
    Zhendan Yao
    Nan Zhang
    Xiangqian Su
    International Journal of Colorectal Disease, 2016, 31 : 123 - 129
  • [36] Prognostic and predictive value of a lncRNA signature in patients with stage II colon cancer
    Ailin Qu
    Qian Wang
    Qing Chang
    Jingkang Liu
    Yongmei Yang
    Xin Zhang
    Yanli Zhang
    Xiaoshi Zhang
    Hongchun Wang
    Yi Zhang
    Scientific Reports, 13
  • [37] Deficient mismatch repair as a prognostic marker in stage II colon cancer patients
    Gkekas, Ioannis
    Novotny, Jan
    Fabian, Pavel
    Nemecek, Radim
    Palmqvist, Richard
    Strigard, Karin
    Pecen, Ladislav
    Svoboda, Tomas
    Gurlich, Robert
    Gunnarsson, Ulf
    EJSO, 2019, 45 (10): : 1854 - 1861
  • [38] Prognostic impact of mutation profiling in patients with stage II and III colon cancer
    Yinchen Shen
    Xiaohong Han
    Jianfei Wang
    Shuai Wang
    Hongying Yang
    Shih-Hsin Lu
    Yuankai Shi
    Scientific Reports, 6
  • [39] Prognostic impact of mutation profiling in patients with stage II and III colon cancer
    Shen, Yinchen
    Han, Xiaohong
    Wang, Jianfei
    Wang, Shuai
    Yang, Hongying
    Lu, Shih-Hsin
    Shi, Yuankai
    SCIENTIFIC REPORTS, 2016, 6
  • [40] Development and Independent Validation of a Prognostic Assay for Stage II Colon Cancer Using Formalin-Fixed Paraffin-Embedded Tissue
    Kennedy, Richard D.
    Bylesjo, Max
    Kerr, Peter
    Davison, Timothy
    Black, Julie M.
    Kay, Elaine W.
    Holt, Robert J.
    Proutski, Vitali
    Ahdesmaki, Miika
    Farztdinov, Vadim
    Goffard, Nicolas
    Hey, Peter
    McDyer, Fionnuala
    Mulligan, Karl
    Mussen, Julie
    O'Brien, Eamonn
    Oliver, Gavin
    Walker, Steven M.
    Mulligan, Jude M.
    Wilson, Claire
    Winter, Andreas
    O'Donoghue, Diarmuid
    Mulcahy, Hugh
    O'Sullivan, Jacintha
    Sheahan, Kieran
    Hyland, John
    Dhir, Rajiv
    Bathe, Oliver F.
    Winqvist, Ola
    Manne, Upender
    Shanmugam, Chandrakumar
    Ramaswamy, Sridhar
    Leon, Eduardo J.
    Smith, William I., Jr.
    McDermott, Ultan
    Wilson, Richard H.
    Longley, Daniel
    Marshall, John
    Cummins, Robert
    Sargent, Daniel J.
    Johnston, Patrick G.
    Harkin, D. Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (35) : 4620 - 4626
12345